Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model

References

• Abyaneh HS, Vakili MR, Lavasanifar A. 2014. The effect of polymerization method in stereo-active block copolymers on the stability of polymeric micelles and their drug release profile. Pharm Res. 31:1485–1500.
   PubMed Web of Science ®Google Scholar
• Ahmad Z, Shah A, Siddiq M, Kraatz HB. 2014. Polymeric micelles as drug delivery vehicles. RSC Adv. 4:17028–17038.
   Web of Science ®Google Scholar
• Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K. 2005. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst. 1:242–250.
   PubMed Web of Science ®Google Scholar
• Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. 2007. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol. 5:1–18.
   PubMedGoogle Scholar
• Brewer TG, Peggins JO, Grate SJ, Petras J, Levine BS, Weina PJ, et al. 1994. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 88:33–36.
   PubMed Web of Science ®Google Scholar
• Bystrom LM, Guzman ML, Rivella S. 2014. Iron and reactive oxygen species: friends or foes of cancer cells? Antioxid Redox Signal. 20:1917–1924.
   PubMed Web of Science ®Google Scholar
• Chen D, Jiang X, Liu J, Jin X, Zhang C, Ping Q. 2010. In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Artif Cells Blood Substit Biotechnol. 38:136–142.
   PubMed Web of Science ®Google Scholar
• Dhankhar R, Vyas SP, Jain AK, Arora S, Rath G, Goyal AK. 2010. Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol. 38:230–249.
   PubMed Web of Science ®Google Scholar
• Esserman L, Takahashi S, Rojas V, Warnke R, Levy R. 1989. An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas. Blood. 74:2718–2729.
   PubMed Web of Science ®Google Scholar
• Farsam V, Hassan ZM, Zavaran-Hosseini A, Noori S, Mahdavi M, Ranjbar M. 2011. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo. Int Immunopharmacol. 11:1802–1808.
   PubMed Web of Science ®Google Scholar
• Ferreira JFS, Luthria DL, Sasaki T, Heyerick A. 2010. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Mol Basel Switz. 15:3135–3170.
   Google Scholar
• Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY. 1983. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol. 36:539–545.
   PubMed Web of Science ®Google Scholar
• Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. 2010. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today. 15:668–678.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899.
   PubMed Web of Science ®Google Scholar
• Gupta S, Chadha R. 2013. Studies on the preparation and evaluation of antimalarial activity of arteether and complexed arteether with β-CD loaded chitosan/lecithin nanoparticles. Pharm Nanotechnol. 1:204–212.
   Google Scholar
• Hosseini M, Haji-Fatahaliha M, Jadidi-Niaragh F, Majidi J, Yousefi M. 2016. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy. Artif Cells Nanomed Biotechnol. 44:1051–1061.
   PubMed Web of Science ®Google Scholar
• Iversen TG, Skotland T, Sandvig K. 2011. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 6:176–185.
   Web of Science ®Google Scholar
• Jiao Y, Ge C, Meng Q, Cao J, Tong J, Fan S. 2007. Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin. 28:1045–1056.
   PubMed Web of Science ®Google Scholar
• Ke XY, Ng VWL, Gao SJ, Tong YW, Hedrick JL, Yang YY. 2014. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 35:1096–1108.
   PubMed Web of Science ®Google Scholar
• Khosroushahi AY, Naderi-Manesh H, Yeganeh H, Barar J, Omidi Y. 2012. Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities. J Nanobiotechnol. 10:2–15.
   PubMed Web of Science ®Google Scholar
• Kim D, Lee ES, Oh KT, Gao ZG, Bae YH. 2008. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. Small Weinh Bergstr Ger. 4:2043–2050.
   PubMed Web of Science ®Google Scholar
• Kjær A, Verstappen F, Bouwmeester H, Ivarsen E, Fretté X, Christensen LP, Grevsen K, Jensen M. 2013. Artemisinin production and precursor ratio in full grown Artemisia annua L. plants subjected to external stress. Planta. 237:955–966.
   PubMed Web of Science ®Google Scholar
• Langroudi L, Hassan ZM, Ebtekar M, Mahdavi M, Pakravan N, Noori S. 2010. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model. Int Immunopharmacol. 10:1055–1061.
   PubMed Web of Science ®Google Scholar
• Lee ES, Gao Z, Kim D, Park K, Kwon IC, Bae YH. 2008. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Control Release. 129:228–236.
   PubMed Web of Science ®Google Scholar
• Mohamadabadi MA, Hassan ZM, Hosseini AZ, Noori S, Mahdavi M, Maroufizadeh S, Maroof H. 2013. Study of immunomodulatory effects of arteether administrated intratumorally. Iran J Allergy Asthma Immunol. 12:57–62.
   PubMed Web of Science ®Google Scholar
• Nakase I, Lai H, Singh NP, Sasaki T. 2008. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm. 354:28–33.
   PubMed Web of Science ®Google Scholar
• Nazir S, Hussain T, Ayub A, Rashid U, MacRobert AJ. 2014. Nanomaterials in combating cancer: Therapeutic applications and developments. Nanomed Nanotechnol Biol Med. 10:19–34.
   PubMed Web of Science ®Google Scholar
• Njuguna NM, Ongarora DS, Chibale K. 2012. Artemisinin derivatives: a patent review (2006-present). Expert Opin Ther Pat. 22:1179–1203.
   PubMed Web of Science ®Google Scholar
• Qu JB, Shao HH, Jing GL, Huang F. 2013. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 102:37–44.
   PubMed Web of Science ®Google Scholar
• Rahman M, Kumar V, Beg S, Sharma G, Katare OP, Anwar F. 2016. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artif Cells Nanomed Biotechnol. 44. [Epub ahead of print]. doi: 10.3109/21691401.2015.1129617.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. 2010. Endocytosis of nanomedicines. J Control Release. 145:182–195.
   PubMed Web of Science ®Google Scholar
• Santerre JP, Woodhouse K, Laroche G, Labow RS. 2005. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials. 26:7457–7470.
   PubMed Web of Science ®Google Scholar
• Savic R, Luo L, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 300:615–618.
   PubMed Web of Science ®Google Scholar
• Shakir L, Hussain M, Javeed A, Ashraf M, Riaz A. 2011. Artemisinins and immune system. Eur J Pharmacol. 668:6–14.
   PubMed Web of Science ®Google Scholar
• Singh J, Jain K, Mehra NK, Jain NK. 2016. Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers. Artif Cells Nanomed Biotechnol. 44. [Epub ahead of print]. doi: 10.3109/21691401.2015.1129625.
   Web of Science ®Google Scholar
• Tran TH, Nguyen AN, Kim JO, Yong CS, Nguyen CN. 2016. Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers. Artif Cells Nanomed Biotechnol. 44. [Epub ahead of print]. doi: 10.3109/21691401.2015.1129616.
   PubMed Web of Science ®Google Scholar
• Vienna S, Wien S. 2015. Cancer nanotechnology. Cancer. 6:1–8.
   Web of Science ®Google Scholar
• Wang B, Zaidi N, He LZ, Zhang L, Kuroiwa JMY, Keler T, Steinman RM. 2012. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Res. 14:R39.
   PubMed Web of Science ®Google Scholar
• Zhou L, Liang D, He X, Li J, Tan H, Li J, Fu Q, Gu Q. 2012. The degradation and biocompatibility of pH-sensitive biodegradable polyurethanes for intracellular multifunctional antitumor drug delivery. Biomaterials. 33:2734–2745.
   PubMed Web of Science ®Google Scholar
• Zhu L, Perche F, Wang T, Torchilin VP. 2014. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials. 35:4213–4222.
   PubMed Web of Science ®Google Scholar